Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Bayer-allied NextRNA Therapeutics winds down operations
The closure comes a year after NextRNA inked a two-program oncology pact with Bayer worth up to $547 million in upfront and milestone payments.
Darren Incorvaia
Aug 11, 2025 2:30pm
Novartis scores double phase 3 win in Sjögren's syndrome
Aug 11, 2025 4:33am
Fierce Biotech Layoff Tracker 2025: Poseida, Absci & more
Aug 11, 2025 2:50pm
SetPoint nets $140M following FDA neuromod approval in RA
Aug 11, 2025 11:30am
Expedition inks $645M Fosun deal to bring China asset to US
Aug 11, 2025 11:06am
Cancer vaccine’s ‘narrow’ fail won’t stop IO heading to FDA
Aug 11, 2025 9:48am
More News
Biotech founder debuts tool to find microprotein drug targets
Aug 11, 2025 7:00am
Fierce Pharma
Vinay Prasad is back at the FDA after last month's surprise ouster
Aug 9, 2025 12:22pm
FDA denies request to reconsider Stealth's ultrarare disease med
Aug 8, 2025 1:58pm
10x Genomics scoops up Scale Bio for single-cell analysis
Aug 8, 2025 12:22pm